In This Episode
Happy New Year, friends! Today’s show is from a live webinar that Neal hosted after he and his staff got their first doses of the Covid vaccine. So along with details of their various reactions, Neal talks about priority groups for the roll-out, explains vaccine profits, who stands to benefit if a vaccine fails, and gets into the ingredient lists for the vaccines available now.
Topics Discussed
- Priority groups
- Lists of underlying conditions and compromised immune diseases
- Does vax brand matter
- Vaccines are not profitable
- The civilian attention paid to this vax
- Who gains from vax failure
- Rare adverse reactions
- Neal’s staff’s reactions to their shots
- Vax ingredients
- Anticipated length of efficacy
- MRNA and DNA
- Q&A
Resources
- Unedited Video Of This Webinar
- Dr. Neal’s Slidedeck
- The Washington Post’s Immunization Tracker
- Ulster County Vaccination Resource Center
